 |
Debiopharm SA is the second biggest biotechnology company
in Switzerland. |
 |
Quantum Genomics is a global Biotechnology company maximizing the developments
and discoveries of academic research into breakthrough treatments for human
disease. |
 |
Xigen is a swiss biotechnology company developing intracellular peptide
therapeutics for the treatment of stroke, myocardial infarction and cancer. |
| |
|
 |
Rodman and Renshaw, based in New York, is the biggest broker for biotechnology
in the world. |
 |
Seventure, formerly SPEF Venture, targets mostly information technologies
and Lifescience companies. |
 |
Affix Corporate Finance is a recently established Belgian Investment brokerage
firm engaged in corporate finance services to Benelux and French corporations.
|
 |
BioAlps is an association whose aim is to promote Western Switzerland as a European pole
in matters of life sciences, to promote its education and research institutions as well as
the enterprises related to the sector. |